JLand Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 3

JLand Biotech General Information

Description

Developer and manufacturer of non-animal collagen. The company focuses on the design and industrial application of recombinant collagen with bioengineering technologies such as genetic recombination, microbial fermentation, protein separation and purification, providing industries such as cosmetics and food with non-animal sourced collagen products.

Contact Information

Website
www.jlandbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1701, Building S3
  • Herui Technology Plaza
  • Hangzhou, Zhejiang
  • China
+86 0523
Primary Industry
Biotechnology
Vertical(s)
LOHAS & Wellness, Manufacturing, Life Sciences
Corporate Office
  • Room 1701, Building S3
  • Herui Technology Plaza
  • Hangzhou, Zhejiang
  • China
+86 0523

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JLand Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 12-Sep-2023 Completed Generating Revenue
1. Later Stage VC (Series A) 30-Jun-2021 Completed Generating Revenue
To view JLand Biotech’s complete valuation and funding history, request access »

JLand Biotech Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • Pending

  • Expiring in next 12 mo

JLand Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11104928-B2 Fermentation process with pichia yeast expressing recombinant protein Active 22-Jul-2016
US-20190309339-A1 Fermentation process with pichia yeast expressing recombinant protein Active 22-Jul-2016
US-11136373-B2 Fermentation process for increasing production level of recombinant human collagen Active 22-Jul-2016
US-20190241645-A1 Fermentation process for increasing production level of recombinant human collagen Active 22-Jul-2016
EP-3473725-A1 Fermentation technique with pichia yeast expressing recombinant protein Active 22-Jul-2016 C12P21/02
To view JLand Biotech’s complete patent history, request access »

JLand Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cenova Capital Venture Capital Minority
Evonik Venture Capital Corporate Venture Capital Minority
Addor Capital Growth/Expansion Minority
To view JLand Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial

JLand Biotech FAQs

  • When was JLand Biotech founded?

    JLand Biotech was founded in 2015.

  • Where is JLand Biotech headquartered?

    JLand Biotech is headquartered in Hangzhou, China.

  • What industry is JLand Biotech in?

    JLand Biotech’s primary industry is Biotechnology.

  • Is JLand Biotech a private or public company?

    JLand Biotech is a Private company.

  • What is JLand Biotech’s current revenue?

    The current revenue for JLand Biotech is .

  • Who are JLand Biotech’s investors?

    Cenova Capital, Evonik Venture Capital, and Addor Capital have invested in JLand Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »